Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer

Sean V. Tavtigian(University of Utah), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), John L. Hopper(The University of Melbourne), David C. Whiteman(Queensland Health), Graham Byrnes(Centre international de recherche sur le cancer), Catherine Voegele(Centre international de recherche sur le cancer), Mia Hashibe(University of California, Los Angeles), Nathalie Forey(Centre international de recherche sur le cancer), Esther M. John, Irene L. Andrulis(University of Toronto), Maxime Vallée(Hospices Civils de Lyon), Shu‐Chun Chuang(UCLA Health), Suleeporn Sangrajrang(National Cancer Institute of Thailand), Lydie Gioia(Centre international de recherche sur le cancer), A. Hartmann, Alun Thomas(University of Utah), Barbara Herte(University of Regensburg), Fabienne Lesueur(Inserm), Peter J. Oefner, Corinna Feuchtinger(University of Regensburg), Sandrine McKay‐Chopin(Centre international de recherche sur le cancer), Melissa C. Southey(The University of Melbourne), Florence Le Calvez‐Kelm(Centre international de recherche sur le cancer), Sue Healey(QIMR Berghofer Medical Research Institute), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Janet Hall(Centre international de recherche sur le cancer), Davit Babikyan(Centre international de recherche sur le cancer)
The American Journal of Human Genetics
September 25, 2009
Cited by 194


Related Papers